Merrem 1g Single-Dose IV Vial from Canada
Merrem brand meropenem 1g lyophilized powder in a single-dose glass vial for IV push or infusion, indicated for bacterial meningitis and pneumonia. This product is specifically under HTS 3004.20.00.76 for containing meropenem salts in measured doses for retail pharmacy or hospital sale. It's a finished therapeutic product excluding vaccines or waste pharmaceuticals.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Provide trademark authorization letters if importing branded products to prevent IP seizure at customs
• Conduct pre-shipment testing for endotoxin levels to meet USP standards and avoid FDA detention
• Declare exact measured dose on commercial invoice to match HTS statistical reporting requirements